Jo C. Neill

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.

Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.

Journal: Neurochemical research

Published: July 13, 2023

Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.

Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.

Journal: Neurochemical research

Published: March 14, 2023

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.

Journal: Journal of psychopharmacology (Oxford, England)

Published: February 02, 2022

Cognitive dysfunction in major depression: From assessment to novel therapies.

Cognitive dysfunction in major depression: From assessment to novel therapies.

Journal: Pharmacology & therapeutics

Published: February 01, 2019

Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects.

Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects.

Journal: Brain, behavior, and immunity

Published: June 15, 2018

NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.

NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.

Journal: Neuropharmacology

Published: August 31, 2017

Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine.

Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine.

Journal: Journal of psychopharmacology (Oxford, England)

Published: September 15, 2016

Partial agonism at the α7 nicotinic acetylcholine receptor improves attention, impulsive action and vigilance in low attentive rats.

Partial agonism at the α7 nicotinic acetylcholine receptor improves attention, impulsive action and vigilance in low attentive rats.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: July 07, 2016

Null is beautiful: On the importance of publishing null results.

Null is beautiful: On the importance of publishing null results.

Journal: Journal of psychopharmacology (Oxford, England)

Published: June 18, 2016

Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model.

Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model.

Journal: Behavioural brain research

Published: May 11, 2016

Low attentive and high impulsive rats: A translational animal model of ADHD and disorders of attention and impulse control.

Low attentive and high impulsive rats: A translational animal model of ADHD and disorders of attention and impulse control.

Journal: Pharmacology & therapeutics

Published: December 01, 2015

A systematic review comparing sex differences in cognitive function in schizophrenia and in rodent models for schizophrenia, implications for improved therapeutic strategies.

A systematic review comparing sex differences in cognitive function in schizophrenia and in rodent models for schizophrenia, implications for improved therapeutic strategies.

Journal: Neuroscience and biobehavioral reviews

Published: November 06, 2015

Showing 1-12 of 25

Last Updated: 09/26/2026